AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,893,055 | -2.9% | 84,319 | -0.2% | 0.66% | +2.0% |
Q2 2023 | $6,069,942 | +16.8% | 84,469 | +0.3% | 0.65% | +6.1% |
Q1 2023 | $5,194,751 | -20.3% | 84,221 | -0.4% | 0.61% | -24.2% |
Q4 2022 | $6,521,342 | +325967.1% | 84,550 | +162496.2% | 0.80% | – |
Q3 2022 | $2,000 | – | 52 | +477.8% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 9 | -93.7% | 0.00% | -100.0% |
Q1 2022 | $6,000 | 0.0% | 143 | -4.7% | 0.00% | 0.0% |
Q4 2021 | $6,000 | -53.8% | 150 | -62.5% | 0.00% | -66.7% |
Q3 2021 | $13,000 | -78.7% | 400 | -55.6% | 0.00% | -78.6% |
Q2 2021 | $61,000 | +19.6% | 900 | 0.0% | 0.01% | +27.3% |
Q1 2021 | $51,000 | -30.1% | 900 | 0.0% | 0.01% | -38.9% |
Q4 2020 | $73,000 | +46.0% | 900 | +28.6% | 0.02% | +28.6% |
Q3 2020 | $50,000 | +1150.0% | 700 | +821.1% | 0.01% | +600.0% |
Q1 2020 | $4,000 | -90.2% | 76 | -81.0% | 0.00% | -85.7% |
Q4 2019 | $41,000 | +310.0% | 400 | 0.0% | 0.01% | +250.0% |
Q2 2019 | $10,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |